Concert Pharmaceuticals Inc. (CNCE) Climbed 7.13% or 1.31 To Price $19.68 On Thursday


Concert Pharmaceuticals Inc. (CNCE) climbed 7.13% or 1.31 to $19.68. It is nearly 312649 shares traded, which is 133.52% compare to the average total volume 234166. The market cap of CNCE is $457.23 million. The year to date change is -32.54%. The 52 week price range is from $11.88 to $30.71. Price of CNCE have changed -2.44% during last week. It have changed -6.56% over last month, -8.20% over last 3 months, 7.74% over last 6 months and 16.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 21.03. It is 6.86% above current price. The 200-day Moving Averages for CNCE is 19.19. It is -2.49% below current price. The 52-week High is 30.71. It is 56.05% from the current price. The 52-week Low is 11.88. It is -39.63% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNCE is 3.72 on 2018-04-13. Short % to float is 4.77%. There are some statistics of CNCE. It is has market cap $457.23 million. The share outstanding is 23.23 million. The average volume is 234166. The revenue is 143.88M. The percent of top 15 Institution holding is 68.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is 67.82%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is 61.28%.


Tags:

Share this post